Search for in this collection

Subscribe to this collection to receive daily e-mail notification of new additions

Preview	Issue Date	Title	Author(s)
	1-Apr-2026	What can I bring to the job? Perceived competencies and job readiness at the conclusion of a pre-registrant training programme.	Walker S.; Lim A. ; Ong E.
	1-Apr-2026	Developing research capacity: Impacts of pre-registrant research training programme for community pharmacy learners.	Walker S.; Lim A. ; Ong E.; Emery B.; Abeyaratne C.
	3-Apr-2026	Kinetics of peanut-specific sIgE and sigg4 during oral immunotherapy (OIT) and remission of allergy.	Ashley S.; Loke P.; Hsiao K.; Lloyd M.; Wang X.; Orsini F.; Tang M.
	3-Apr-2026	Two-year post-treatment outcomes following peanut oral immunotherapy.	Loke P.; Wang X.; Lloyd M.; Lozinsky A.C.; Gold M.; O'Sullivan M.; Quinn P.; Ashley S.; Axelrad C.; Pitkin S.; Metcalfe J.; Fahy-Scheer S.; Belousoff J.; Tey D.; Robinson M.; Su E.L.; Dunn Galvin A.; Orsini F.; Tang M.
	3-Apr-2026	Managing breakthrough disease activity during treatment with natalizumab in relapsing-remitting multiple sclerosis.	Lizak N.; Sharmin S.; Horakova D.; Havrdova E.; Ayuso G.I.; Madueno S.E.; Walt A.V.D.; Butzkueven H.; Lechner-Scott J.; Buzzard K.; Skibina O.; Gerlach O.; Prat A.; Girard M.; Duquette P.; Alroughani R.; Patti F.; Grand'Maison F.; Jose Sa M.; Morales E.A.; Hodgkinson S.; Grammond P.; Kuhle J.; Yamout B.I.; Khoury S.; Ozakbas S.; Slee M.; Csepany T.; John N.A.; Laureys G.; Van Hijfte L.; Terzi M.; Amato M.P.; Boz C.; Al-Asmi A.; Cartechini E.; Gouider R.; Mrabet S.; Roos I.; Kalincik T.
	3-Apr-2026	The MSReactor cognitive platform can detect changes in psychomotor, attention and working memory reaction time performance in progressive MS patients.	Merlo D.; Gresle M.; Zhu C.; Foong Y.C.; Darby D.; Kalincik T.; Lechner-Scott J.; Barnett M.; Buzzard K.; Taylor B.; John N.A.; Kermode A.; Butzkueven H.; van der Walt A.
	3-Apr-2026	The MSReactor cognitive screening tests can detect changes in cognitive function in late-onset multiple sclerosis.	Merlo D.; Gresle M.; Zhu C.; Foong Y.C.; Lechner-Scott J.; Barnett M.; Kalincik T.; Taylor B.; Buzzard K.; John N.A.; Kermode A.; Darby D.; Butzkueven H.; van der Walt A.
	3-Apr-2026	8-year outcomes of enzalutamide (ENZA) versus a non-steroidal anti-androgen (NSAA) for metastatic, hormone-sensitive prostate cancer (ENZAMET; ANZUP 1304).	Zhang A.Y.; Davis I.D.; Thomas H.; McLaughlin R.A.; Tan T.H.; Pook D.W.; Marx G.M.; Zielinski R.R.; Sandhu S.; Thomson A.; Reaume M.N.; North S.A.; McCaffrey J.; McDermott R.S.; Lawrence N.J.; Horvath L.; Chowdhury S.; Chi K.N.; Stockler M.R.; Sweeney C.
	22-Mar-2023	Noninvasive Detection of Lymph Node Involvement in Subjects with Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Breast Cancer using the MagSense HER2 Test Reagent - A First-In-Human Phase 1 Study.	Jayalakshmi Y.; Fox J. ; Yang N.; Zhang M.; Proulx R.; Reich S.
	25-May-2024	MagSense HER2, a Molecularly Targeted Magnetic Resonance Imaging Agent for the Detection of Axillary Nodal Metastasis in Subjects with Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Breast Cancer.	Fox J. ; Velaiutham S.; Yang N.; Lau E.; Murugappan K.; Kumar B. ; Laslowski A.; Govindarajan K.; Reich S.; Thomas S.; Neha N.; Zhang M.; Bright I.
	1-Aug-2025	Verification of the BREASTEST assay in an Australian population: A novel liquid biopsy assay measuring lipid biomarkers for early-stage breast cancer screening.	Speakman D.; Adam K.-P.; Huang T.; Warrier S.; Ooi C.; French J.; Elder E.; Mak C.; Rickard M.; Vincent W.; Poliness C.; Wang K.-C.; Pathmanathan N.; Mann B.; Batarseh A.; Hurrell J.; Vafaee F.; Preston S.
	24-Aug-2017	Design of a 3-DOF parallel mechanism for the enhancement of endonasal surgery	Nowell R.; Shirinzadeh B.; Lai L. ; Smith J. ; Zhong Y.
	23-May-2023	Does Physical Activity Improve Patient Outcomes Following Lumbar Microdiscectomy?.	Yang A.; Goldschlager T. ; Daly C.D.; Castle-Kirszbaum M.; Rogers M.A.
	22-Feb-2018	Intervertebral disc repair following microdiscectomy mediated by pentosan polysulfate primed mesenchymal progenitor cells in an ovine model.	Daly C.D.; Ghosh P.; Badal T.; Shimmon R.; Ghosh I.; Jenkin G. ; Oehme D.A.; Sher I.; Chandra R.V.; Vais A.; Cohen C.; Goldschlager T.
	27-Jun-2021	Biomarkers for the early diagnosis of sepsis in burns: Systematic review and metaanalysis.	Li A.; Moussa A.; Gus E.; Paul E.; Yii E.; Romero L.; Lo C.H.; Cleland H.J.
	3-Mar-2026	Large scale case-control analyses of rare variant data; application to BRCA1 and BRCA2.	O'Mahony D.; Zanti M.; Parsons M.T.; Dennis J.; Fortuno C.; Vreeswijk M.; de la Hoya M.; Walker L.; Southey M.C.; Devilee P.; James P.; Goldgar D.E.; Easton D.F.; Spurdle A.B.; Michailidou K.
	5-Mar-2026	A randomized controlled trial of cognitive behavioral therapy and bright light therapy for insomnia and fatigue during breast cancer treatment: SleepCaRe trial.	Wiley J.F.; Do T.T.; Maccora J.; Wallace R.; Aedo-Lopez V.; Alexander M.; Bei B.; Blum R.H.; Boyle F.M.; Day D. ; Diggens J.; Francis P.A.; Ftanou M.; Garland S.N.; Mortimer D.; Sharma S.; Stafford L.; White M.A.
	5-Mar-2026	PYNNACLE phase 2 clinical trial of rezatapopt in patients with advanced solid tumors harboring a TP53 Y220C mutation.	Schram A.M.; Frenel J.-S.; Johnson M.L.; Italiano A.; Kummar S.; Coveler A.L.; Spira A.I.; Body A. ; Fontana E.; Garralda E.; Greystoke A.; Millward M.; Scambia G.; Tan D.S.P.; Fellous M.M.; Dumbrava E.E.; Lopes G.
	6-Mar-2026	An audit and analysis of the implementation of COVID-19 policy within a tertiary referral hospital, from the perspective of a junior medical officer.	Courtney A.; Silvers A.; Licina A.
	9-Mar-2026	G.P.13.07 Prevalence and diagnosis of sporadic inclusion body myositis (sIBM) in Western Australia.	Needham M.; Corbett A.; Day T.; Fabian V.; Mastaglia F.